SRI 2023 rodent and non-rodent pharmacokinetic studies
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $249,318
Award facts
- Contract value 17% obligated
-
- $249,318.00 Current, with exercised options
- $1,469,307.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $124,659 | |
| Exercise an Option | $51,947 | |
| Original award | $72,712 |
About this award
This federal contract award to SRI International, a non-profit research and development institute, is for $1,469,307.00 to conduct rodent and non-rodent pharmacokinetic studies. The contract is a delivery order issued under the Pharmacology and Toxicology for Therapeutics Program (PTTP) master IDIQ contract with the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The work will take place in Rockville, Maryland, with a completion date of July 2, 2026. The contract does not have a small business set-aside designation.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on July 3, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $249,318 on 75N95023F00001. Its potential value, with all options, is $1,469,307.
Which agency awarded contract 75N95023F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under HHSN271201600006I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award